Silencing of wtp53 in melanoma cells significantly decreased the tumour growth inhibitory activity of SLMP53-2, which further reinforced the p53-dependent antitumor activity of SLMP53-2 unveiled in our previous work [19]. The gene discussed is TP53; the disease is melanoma.